• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宫颈癌各种筛查方式的检测特征:一项为资源有限地区制定替代策略的可行性研究。

Test characteristics of various screening modalities for cervical cancer: a feasibility study to develop an alternative strategy for resource-limited settings.

作者信息

Sodhani P, Gupta S, Sharma J K, Parashari A, Halder K, Singh V, Sehgal A

机构信息

Division of Cytopathology, Institute of Cytology and Preventive Oncology (ICMR), NOIDA, Uttar Pradesh, India.

出版信息

Cytopathology. 2006 Dec;17(6):348-52. doi: 10.1111/j.1365-2303.2006.00351.x.

DOI:10.1111/j.1365-2303.2006.00351.x
PMID:17168917
Abstract

OBJECTIVE

To determine test characteristics - sensitivity, specificity, positive and negative predictive values - of different screening modalities to detect cervical precancerous and cancerous lesions in order to devise an effective alternative strategy for cervical cancer screening in resource-poor settings.

METHODS

A total of 472 women presenting with nonspecific gynecologic symptoms were screened by cytology, visual inspection with acetic acid application (VIA), VIA with magnification (VIAM) and human papillomavirus (HPV)-DNA testing. Colposcopic examination was performed in all and on-site biopsy was taken if any grade I and above lesion was detected on colposcopy (230). On histopathological examination, 105 showed cervical intraepithelial neoplasia II and above lesions. Sensitivity, specificity and predictive values for each test were calculated taking colposcopy and or directed biopsy as the gold standard. Comparisons were made with cytology in order to assess the feasibility of alternative strategies in resource-poor settings.

RESULTS

VIA was less sensitive (86.7% versus 91.4%) but more specific (90.7% versus 86.6%) than cytology at low grade squamous intraepithelial lesion (LSIL) threshold but the difference was not statistically significant (P > 0.01). HPV testing improved the sensitivity over cytology (97.1% versus 91.4%) but there was a nonsignificant loss of specificity (84.2% versus 86.6%). Results of VIAM were more or less similar to VIA.

CONCLUSION

VIA can be used as a mass screening tool for cervical cancer in resource-poor settings.

摘要

目的

确定不同筛查方式检测宫颈癌前病变和癌性病变的检测特征——敏感性、特异性、阳性和阴性预测值,以便为资源匮乏地区设计一种有效的宫颈癌筛查替代策略。

方法

对472名出现非特异性妇科症状的女性进行了细胞学检查、醋酸涂抹肉眼观察(VIA)、放大醋酸涂抹肉眼观察(VIAM)和人乳头瘤病毒(HPV)-DNA检测。对所有人进行了阴道镜检查,如果在阴道镜检查中发现任何I级及以上病变,则进行现场活检(230例)。经组织病理学检查,105例显示宫颈上皮内瘤变II级及以上病变。以阴道镜检查和/或定向活检为金标准,计算每项检测的敏感性、特异性和预测值。与细胞学检查进行比较,以评估资源匮乏地区替代策略的可行性。

结果

在低级别鳞状上皮内病变(LSIL)阈值下,VIA的敏感性低于细胞学检查(86.7%对91.4%),但特异性高于细胞学检查(90.7%对86.6%),但差异无统计学意义(P>0.01)。HPV检测比细胞学检查提高了敏感性(97.1%对91.4%),但特异性略有下降(84.2%对86.6%),差异无统计学意义。VIAM的结果与VIA大致相似。

结论

VIA可作为资源匮乏地区宫颈癌的大规模筛查工具。

相似文献

1
Test characteristics of various screening modalities for cervical cancer: a feasibility study to develop an alternative strategy for resource-limited settings.宫颈癌各种筛查方式的检测特征:一项为资源有限地区制定替代策略的可行性研究。
Cytopathology. 2006 Dec;17(6):348-52. doi: 10.1111/j.1365-2303.2006.00351.x.
2
Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.25 岁及以上女性宫颈癌筛查中致癌型人乳头瘤病毒(HPV)检测及 HPV16 或 HPV18 基因分型的性能:ATHENA 研究的一项亚组分析。
Lancet Oncol. 2011 Sep;12(9):880-90. doi: 10.1016/S1470-2045(11)70188-7. Epub 2011 Aug 22.
3
Screening of cervical neoplasia in HIV-infected women in India.印度 HIV 感染女性的宫颈癌筛查。
AIDS. 2013 Feb 20;27(4):607-15. doi: 10.1097/QAD.0b013e32835b1041.
4
Visual inspection with acetic acid and cytology in the early detection of cervical neoplasia in Kolkata, India.印度加尔各答采用醋酸目视检查和细胞学检查早期发现宫颈肿瘤
Int J Gynecol Cancer. 2003 Sep-Oct;13(5):626-32. doi: 10.1046/j.1525-1438.2003.13394.x.
5
Cytology versus HPV testing for cervical cancer screening in the general population.普通人群宫颈癌筛查中细胞学检查与HPV检测的比较
Cochrane Database Syst Rev. 2017 Aug 10;8(8):CD008587. doi: 10.1002/14651858.CD008587.pub2.
6
Long term results of follow-up after HPV self-sampling with devices Qvintip and HerSwab in women non-attending cervical screening programme.HPV 自我采样装置 Qvintip 和 HerSwab 在未参加宫颈癌筛查项目女性中的随访长期结果。
Radiol Oncol. 2021 Jan 6;55(2):187-195. doi: 10.2478/raon-2021-0001.
7
[A study of cervical cancer screening algorithms].[宫颈癌筛查算法的研究]
Zhonghua Zhong Liu Za Zhi. 2010 Jun;32(6):420-4.
8
Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.在随机环境中对原发性人乳头瘤病毒筛查与传统细胞学进行特定年龄评估。
J Natl Cancer Inst. 2009 Dec 2;101(23):1612-23. doi: 10.1093/jnci/djp367. Epub 2009 Nov 9.
9
Concurrent evaluation of visual, cytological and HPV testing as screening methods for the early detection of cervical neoplasia in Mumbai, India.在印度孟买,对视觉检查、细胞学检查和人乳头瘤病毒检测作为宫颈癌前病变早期检测筛查方法进行同步评估。
Bull World Health Organ. 2005 Mar;83(3):186-94. Epub 2005 Mar 16.
10
[Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].[联合高危型人乳头瘤病毒DNA检测与细胞学检测以发现早期宫颈发育异常]
Zhonghua Fu Chan Ke Za Zhi. 2006 Jan;41(1):34-7.

引用本文的文献

1
A scoping review of evidence on routine cervical cancer screening in South Asia: investigating factors affecting adoption and implementation.南亚宫颈癌常规筛查证据的范围综述:调查影响采用和实施的因素
Cancer Causes Control. 2025 Jan;36(1):67-79. doi: 10.1007/s10552-024-01923-y. Epub 2024 Oct 7.
2
Performance of visual Inspection With Acetic Acid for Cervical Cancer Screening as Compared to Human papillomavirus Deoxyribonucleic acid Testing Among Women With HIV in Ethiopia: A Comparative Cross-sectional Study.埃塞俄比亚 HIV 感染女性中醋酸染色肉眼观察用于宫颈癌筛查的表现与 HPV DNA 检测的比较:一项比较性横断面研究。
Cancer Control. 2022 Jan-Dec;29:10732748221114980. doi: 10.1177/10732748221114980.
3
Evaluating the Performance of Hybrid Capture 2 Test as a Primary Screening Test from Studies Conducted in Low and Middle-Income Country Settings- Special Focus India.
从在低收入和中等收入国家开展的研究(特别关注印度)评估杂交捕获2检测作为初筛检测的性能
Asian Pac J Cancer Prev. 2021 Aug 1;22(8):2709-2716. doi: 10.31557/APJCP.2021.22.8.2709.
4
Cervical Cancer Screening in Resource-Constrained Countries: Current Status and Future Directions.资源有限国家的宫颈癌筛查:现状与未来方向
Asian Pac J Cancer Prev. 2017 Jun 25;18(6):1461-1467. doi: 10.22034/APJCP.2017.18.6.1461.
5
Burden of cervical cancer and role of screening in India.印度宫颈癌负担及筛查的作用。
Indian J Med Paediatr Oncol. 2016 Oct-Dec;37(4):278-285. doi: 10.4103/0971-5851.195751.
6
Clinical Practice Guidelines on the Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention in Saudi Arabia.沙特阿拉伯宫颈癌预防癌前病变筛查与治疗临床实践指南
Ann Saudi Med. 2016 Sep-Oct;36(5):313-320. doi: 10.5144/0256-4947.2016.313.
7
Design of a Novel Low Cost Point of Care Tampon (POCkeT) Colposcope for Use in Resource Limited Settings.一种用于资源有限环境的新型低成本即时护理棉塞式(POCkeT)阴道镜的设计
PLoS One. 2015 Sep 2;10(9):e0135869. doi: 10.1371/journal.pone.0135869. eCollection 2015.
8
Cancer Screening: Should Cancer Screening be Essential Component of Primary Health Care in Developing Countries?癌症筛查:癌症筛查应成为发展中国家初级卫生保健的重要组成部分吗?
Int J Prev Med. 2015 Jul 6;6:56. doi: 10.4103/2008-7802.160053. eCollection 2015.
9
Advancing cervical cancer prevention in India: implementation science priorities.推进印度宫颈癌预防工作:实施科学优先事项。
Oncologist. 2013;18(12):1285-97. doi: 10.1634/theoncologist.2013-0292. Epub 2013 Nov 11.
10
Integrating cervical cancer and genital tract infection screening into mother, child health and family planning clinics in Eldoret, Kenya.将宫颈癌和生殖道感染筛查纳入肯尼亚埃尔多雷特的母婴健康及计划生育诊所。
Afr Health Sci. 2010 Mar;10(1):58-65.